Drug therapy: Thiazolidinediones

[1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3149 - 3153

[2] Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 627 - 636

[3] [Anonymous], N ENGL J MED

[4] Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) : 263 - 274

[5] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83

[6] Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J]. DIABETES CARE, 2000, 23 (11) : 1605 - 1611

[7] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1626 - 1632

[8] Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 200 - 206

[9] Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes [J]. DIABETES, 2003, 52 (06) : 1364 - 1370

[10] Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 717 - 726

[1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3149 - 3153

[2] Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 627 - 636

[3] [Anonymous], N ENGL J MED

[4] Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) : 263 - 274

[5] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83

[6] Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J]. DIABETES CARE, 2000, 23 (11) : 1605 - 1611

[7] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1626 - 1632

[8] Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 200 - 206

[9] Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes [J]. DIABETES, 2003, 52 (06) : 1364 - 1370

[10] Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 717 - 726